vs
Lantheus Holdings, Inc.（LNTH）とOSI SYSTEMS INC（OSIS）の財務データ比較。上の社名をクリックして会社を切り替えられます
OSI SYSTEMS INCの直近四半期売上が大きい（$464.1M vs $406.8M、Lantheus Holdings, Inc.の約1.1倍）。Lantheus Holdings, Inc.の純利益率が高く（13.3% vs 8.3%、差は5.0%）。OSI SYSTEMS INCの前年同期比売上増加率が高い（10.5% vs 4.0%）。Lantheus Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$81.4M vs $55.5M）。過去8四半期でOSI SYSTEMS INCの売上複合成長率が高い（7.0% vs 4.9%）
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
OSIシステムズ社は米国カリフォルニア州に本社を置く企業で、空港保安用X線検査装置・金属探知機などのセキュリティ検査システム、医療用モニタリング・麻酔システム、光電子デバイスの開発・販売を手がけ、子会社にSpacelabs Healthcare、Rapiscan Systems、OSI Optoelectronicsがあり、全世界で約3180人の従業員を擁する。
LNTH vs OSIS — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $406.8M | $464.1M |
| 純利益 | $54.1M | $38.7M |
| 粗利率 | 59.2% | 32.7% |
| 営業利益率 | 19.0% | 12.7% |
| 純利益率 | 13.3% | 8.3% |
| 売上前年比 | 4.0% | 10.5% |
| 純利益前年比 | 558.8% | 2.3% |
| EPS（希薄化後） | $0.86 | $2.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $406.8M | $464.1M | ||
| Q3 25 | $384.0M | $384.6M | ||
| Q2 25 | $378.0M | $505.0M | ||
| Q1 25 | $372.8M | $444.4M | ||
| Q4 24 | $391.1M | $419.8M | ||
| Q3 24 | $378.7M | $344.0M | ||
| Q2 24 | $394.1M | $480.9M | ||
| Q1 24 | $370.0M | $405.4M |
| Q4 25 | $54.1M | $38.7M | ||
| Q3 25 | $27.8M | $20.6M | ||
| Q2 25 | $78.8M | $52.7M | ||
| Q1 25 | $72.9M | $41.1M | ||
| Q4 24 | $-11.8M | $37.8M | ||
| Q3 24 | $131.1M | $17.9M | ||
| Q2 24 | $62.1M | $44.7M | ||
| Q1 24 | $131.1M | $34.0M |
| Q4 25 | 59.2% | 32.7% | ||
| Q3 25 | 57.9% | 32.0% | ||
| Q2 25 | 63.8% | 33.3% | ||
| Q1 25 | 63.8% | 33.8% | ||
| Q4 24 | 63.5% | 35.1% | ||
| Q3 24 | 63.9% | 35.3% | ||
| Q2 24 | 64.9% | 32.1% | ||
| Q1 24 | 65.4% | 33.6% |
| Q4 25 | 19.0% | 12.7% | ||
| Q3 25 | 11.4% | 8.6% | ||
| Q2 25 | 23.3% | 14.5% | ||
| Q1 25 | 27.4% | 12.7% | ||
| Q4 24 | 29.1% | 13.8% | ||
| Q3 24 | 35.3% | 8.8% | ||
| Q2 24 | 26.1% | 13.1% | ||
| Q1 24 | 28.8% | 12.7% |
| Q4 25 | 13.3% | 8.3% | ||
| Q3 25 | 7.2% | 5.3% | ||
| Q2 25 | 20.8% | 10.4% | ||
| Q1 25 | 19.6% | 9.3% | ||
| Q4 24 | -3.0% | 9.0% | ||
| Q3 24 | 34.6% | 5.2% | ||
| Q2 24 | 15.8% | 9.3% | ||
| Q1 24 | 35.4% | 8.4% |
| Q4 25 | $0.86 | $2.22 | ||
| Q3 25 | $0.41 | $1.18 | ||
| Q2 25 | $1.12 | $3.04 | ||
| Q1 25 | $1.02 | $2.40 | ||
| Q4 24 | $-0.18 | $2.22 | ||
| Q3 24 | $1.79 | $1.05 | ||
| Q2 24 | $0.88 | $2.57 | ||
| Q1 24 | $1.87 | $1.95 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $359.1M | $336.7M |
| 総負債低いほど良い | $568.7M | $1.0B |
| 株主資本純資産 | $1.1B | $845.5M |
| 総資産 | $2.2B | $2.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.52× | 1.19× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $359.1M | $336.7M | ||
| Q3 25 | $382.0M | $124.4M | ||
| Q2 25 | $695.6M | $106.4M | ||
| Q1 25 | $938.5M | $95.8M | ||
| Q4 24 | $912.8M | $101.6M | ||
| Q3 24 | $866.4M | $85.1M | ||
| Q2 24 | $757.0M | $95.4M | ||
| Q1 24 | $718.3M | $101.4M |
| Q4 25 | $568.7M | $1.0B | ||
| Q3 25 | $567.9M | $442.2M | ||
| Q2 25 | $566.8M | $471.6M | ||
| Q1 25 | $566.1M | $473.2M | ||
| Q4 24 | $565.3M | $474.8M | ||
| Q3 24 | $613.0K | $476.3M | ||
| Q2 24 | $563.2M | $137.6M | ||
| Q1 24 | $562.5M | — |
| Q4 25 | $1.1B | $845.5M | ||
| Q3 25 | $1.1B | $946.0M | ||
| Q2 25 | $1.2B | $951.1M | ||
| Q1 25 | $1.2B | $879.3M | ||
| Q4 24 | $1.1B | $825.8M | ||
| Q3 24 | $1.2B | $786.5M | ||
| Q2 24 | $1.0B | $863.5M | ||
| Q1 24 | $945.5M | $813.4M |
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.3B | $2.3B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | $2.1B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $1.9B | ||
| Q1 24 | $1.8B | $1.8B |
| Q4 25 | 0.52× | 1.19× | ||
| Q3 25 | 0.51× | 0.47× | ||
| Q2 25 | 0.49× | 0.50× | ||
| Q1 25 | 0.49× | 0.54× | ||
| Q4 24 | 0.52× | 0.57× | ||
| Q3 24 | 0.00× | 0.61× | ||
| Q2 24 | 0.55× | 0.16× | ||
| Q1 24 | 0.59× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $90.2M | $62.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $81.4M | $55.5M |
| FCFマージンFCF / 売上 | 20.0% | 12.0% |
| 設備投資強度設備投資 / 売上 | 2.2% | 1.4% |
| キャッシュ転換率営業CF / 純利益 | 1.67× | 1.61× |
| 直近12ヶ月FCF直近4四半期 | $354.1M | $137.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $90.2M | $62.2M | ||
| Q3 25 | $105.3M | $17.1M | ||
| Q2 25 | $87.1M | $562.0K | ||
| Q1 25 | $107.6M | $81.6M | ||
| Q4 24 | $157.7M | $52.5M | ||
| Q3 24 | $175.1M | $-37.2M | ||
| Q2 24 | $84.7M | $-29.0M | ||
| Q1 24 | $127.2M | $-52.1M |
| Q4 25 | $81.4M | $55.5M | ||
| Q3 25 | $94.7M | $10.1M | ||
| Q2 25 | $79.1M | $-5.6M | ||
| Q1 25 | $98.8M | $77.1M | ||
| Q4 24 | $141.4M | $47.1M | ||
| Q3 24 | $159.3M | $-44.9M | ||
| Q2 24 | $73.5M | $-37.5M | ||
| Q1 24 | $119.0M | $-57.0M |
| Q4 25 | 20.0% | 12.0% | ||
| Q3 25 | 24.7% | 2.6% | ||
| Q2 25 | 20.9% | -1.1% | ||
| Q1 25 | 26.5% | 17.4% | ||
| Q4 24 | 36.1% | 11.2% | ||
| Q3 24 | 42.0% | -13.0% | ||
| Q2 24 | 18.7% | -7.8% | ||
| Q1 24 | 32.2% | -14.1% |
| Q4 25 | 2.2% | 1.4% | ||
| Q3 25 | 2.8% | 1.8% | ||
| Q2 25 | 2.1% | 1.2% | ||
| Q1 25 | 2.3% | 1.0% | ||
| Q4 24 | 4.2% | 1.3% | ||
| Q3 24 | 4.2% | 2.2% | ||
| Q2 24 | 2.8% | 1.8% | ||
| Q1 24 | 2.2% | 1.2% |
| Q4 25 | 1.67× | 1.61× | ||
| Q3 25 | 3.79× | 0.83× | ||
| Q2 25 | 1.11× | 0.01× | ||
| Q1 25 | 1.47× | 1.98× | ||
| Q4 24 | — | 1.39× | ||
| Q3 24 | 1.34× | -2.07× | ||
| Q2 24 | 1.36× | -0.65× | ||
| Q1 24 | 0.97× | -1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
OSIS
| Security Division | $334.7M | 72% |
| Optoelectronics And Manufacturing Division | $92.8M | 20% |
| Healthcare Division | $36.5M | 8% |
